AVE 33.3% 0.2¢ avecho biotechnology limited

success! , page-28

  1. 2,314 Posts.
    lightbulb Created with Sketch. 47
    Too tru Markie - lets be real this product is not there to replace the OXY drugs but as a safe and reliable option which the FDA has called out for. There are several players at the moment - of course the Gel formulation listed yesterday by hottod, Endo have also released their non-crushable tablets but really those tablets we've just proven to be ineffective and abusive as our application is far more efficient, targetted and requires less drugs to be included - now what Pharma would want to reduce that and increase the amount of products they can sell with less drug ingredients? Grins.....
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $11.50K 4.335M

Buyers (Bids)

No. Vol. Price($)
63 101422109 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 20872825 7
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.